Immunotherapy: Vaccine trials in melanoma -- time for reflection
- PMID: 19390551
- DOI: 10.1038/nrclinonc.2009.42
Immunotherapy: Vaccine trials in melanoma -- time for reflection
Abstract
The disappointing results of the large, randomized, controlled trials showing no benefit of vaccines in patients with advanced and metastatic melanoma call for a reassessment of the development of therapeutic vaccines and the importance of better immune monitoring methodology, such as adoptive T-cell therapy with lymphodepletion.
Comment on
-
Adoptive cell transfer: a clinical path to effective cancer immunotherapy.Nat Rev Cancer. 2008 Apr;8(4):299-308. doi: 10.1038/nrc2355. Nat Rev Cancer. 2008. PMID: 18354418 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous